| Developers: | Johnson&Johnson |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
Content |
History
2025: Complete Exit from the Market
At the end of September 2025, Johnson & Johnson announced the discontinuation of sales of the Linx Reflux Management System device designed to treat gastroesophageal reflux disease (GERD). As noted, this decision was made "after a thorough assessment of market conditions and opportunities for effective service for each region."
GERD is a chronic recurrent disease caused by impaired motor evacuation function of the organs of the gastroesophageal zone. In this pathology, the contents of the stomach are regularly thrown into the esophagus, which leads to damage to the mucous membrane. As a result, patients may experience replacement of the normal multilayer flat epithelium of the esophagus with a cylindrical epithelium (Barrett's esophagus), which is a precancerous condition. Among the factors contributing to the development of GERD, alcohol abuse, overweight, undergone operations on the stomach and esophagus, ulcers of the stomach and duodenum, as well as excessive consumption of fats, coffee, chocolate, carbonated drinks and products with high acidity are highlighted.
The Linx device allows you to prevent the contents of the stomach from pouring into the esophagus. The product is a flexible ring of small magnets that is placed around the lower esophageal sphincter during a minimally invasive procedure, without requiring a change in the anatomy of the stomach. The magnetic field strength is designed to help the weak sphincter close, which prevents acid reflux. When the patient swallows, Linx opens temporarily, skipping food and fluid. The product does not interfere with the physiological function of burping and vomiting.
The Linx device was recalled in April 2018 after reports of separation of magnets inside the body: because of this, patients needed a second operation to remove the product. Johnson & Johnson fixed the problem but faced lawsuits from those affected. As a result, it was decided to stop selling Linx.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |